Experiments for taxon Basidiomycete species (TO BE DETERMINED)

Experiments (16 results)

16 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
612647	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE		Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC
992050	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL-O-METHYL TRANSFERASE INHIBITION	Basidiomycete species (TO BE DETERMINED)	DICAFFEIC ACID,DEHYDRO: DILACTONE (+):
1202213	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Basidiomycete species (TO BE DETERMINED)	GLYKENIN C,DEACETYL:
14463	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
14464	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
992051	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED	CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITION	Basidiomycete species (TO BE DETERMINED)	DICAFFEIC ACID,DEHYDRO: DILACTONE (+):
1202211	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Basidiomycete species (TO BE DETERMINED)	GLYKENIN A,DEACETYL:
14459	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIYEAST ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
14466	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIBACTERIAL ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
121769	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC GK-IV-ABASIDIOMYCETE ANTIBIOTIC GK-IV-C
14460	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIYEAST ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
992049	UV SPECTRUM GIVEN FORPHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF	TOXICITY ASSESSMENT(QUANTITATIVE)	Basidiomycete species (TO BE DETERMINED)	DICAFFEIC ACID,DEHYDRO: DILACTONE (+):
14465	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
1202212	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Basidiomycete species (TO BE DETERMINED)	GLYKENIN B,DEACETYL:
14462	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T
14461	PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIYEAST ACTIVITY	Basidiomycete species (TO BE DETERMINED)	BASIDIOMYCETE ANTIBIOTIC T